Throne Launches Equity Crowdfunding

To support the United States FDA-approved phase 2 clinical trials of Stem Cell Educator therapy and find a cure for type 1 diabetes and other autoimmune diseases, we are excited to announce that Throne Biotechnologies (Throne) launches the equity crowdfunding today through the platform at StartEngine. We encourage you joining this global effort and saving millions of lives!